Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume $0.55 -0.02 (-3.56%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Elite Pharmaceuticals Short Interest DataElite Pharmaceuticals (ELTP) has a short interest of 2.53 million shares. This marks a 52.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.67 million shares to cover all short positions.Current Short Interest2,526,500 sharesPrevious Short Interest1,654,500 sharesChange Vs. Previous Month+52.70%Dollar Volume Sold Short$1.49 millionShort Interest Ratio0.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,068,273,000 sharesPercentage of Shares Shorted0.24%Today's Trading Volume755,859 sharesAverage Trading Volume1,673,177 sharesToday's Volume Vs. Average45% Short Selling Elite Pharmaceuticals? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20242,526,500 shares $1.49 million +52.7%N/A0.5 $0.59 11/15/20241,654,500 shares $929,001.75 +6.0%N/A0.4 $0.56 10/31/20241,560,500 shares $692,549.90 -22.1%N/A0.1 $0.44 10/15/20242,004,100 shares $883,006.46 -1.6%N/A0.6 $0.44 9/30/20242,036,000 shares $789,968.00 -7.3%N/A0.6 $0.39 9/15/20242,195,500 shares $790,599.55 +19.7%N/A0.2 $0.36 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,834,800 shares $507,597.42 +10.5%N/A0.3 $0.28 8/15/20241,661,100 shares $317,436.21 +5.0%N/A1 $0.19 7/31/20241,581,500 shares $294,159.00 -9.2%N/A1.4 $0.19 7/15/20241,740,800 shares $330,752.00 +7.1%N/A1 $0.19 6/30/20241,625,700 shares $323,514.30 +4.8%N/A1 $0.20 6/15/20241,550,800 shares $261,092.69 -2.4%N/A2.4 $0.17 5/31/20241,588,700 shares $274,845.10 +3.8%N/A1.3 $0.17 5/15/20241,530,700 shares $214,144.93 -4.1%N/A1.3 $0.14 4/30/20241,595,900 shares $207,147.82 -0.3%N/A1.8 $0.13 4/15/20241,601,300 shares $216,175.50 +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240,106.74 -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234,173.30 +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258,066.90 +0.9%N/A0.4 $0.16 2/15/20241,588,800 shares $293,769.12 +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18,008.40 +24.8%N/A0 $0.17 12/31/202382,700 shares $11,578.00 No ChangeN/A0 $0.14 11/30/202380,600 shares $11,084.11 +58.4%N/A0 $0.14 11/15/202350,900 shares $7,380.50 No ChangeN/A0 $0.15 10/15/2023228,000 shares $21,831.00 +113.5%N/A0.3 $0.10 9/30/2023106,800 shares $10,019.44 +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18,629.60 +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2,532.60 +102.4%N/A0 $0.04 7/15/202329,800 shares $1,132.40 No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1,701.70 +44.9%N/A0.1 $0.04This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/31/202330,500 shares $1,030.90 +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1,326.80 No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2,477.48 -2.8%N/A0 $0.04 8/15/202271,300 shares $3,208.50 No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04 2/28/2022212,900 shares $8,516.00 +3,030.9%N/A0.2 $0.04 2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04 1/31/202264,500 shares $2,547.75 No ChangeN/A0.1 $0.04 12/31/2021100 shares $3.31 No ChangeN/A0 $0.03 12/15/2021100 shares $3.70 -99.6%N/A0 $0.04 11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04 11/15/2021100 shares $3.82 -98.9%N/A0 $0.04 10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04 10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04 9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04 8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05 8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05 7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05 7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05 6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05 5/14/202121,600 shares $1,252.80 +151.2%N/A0 $0.06 4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05 3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06 3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06 2/26/202140,400 shares $2,585.60 +1,054.3%N/A0 $0.06 2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07 1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06 12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05 11/30/202027,400 shares $1,479.60 -68.4%N/A0 $0.05 11/15/202086,700 shares $6,675.90 No ChangeN/A0.1 $0.08 10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07 8/31/202073,800 shares $5,830.20 +939.4%N/A0 $0.08 8/14/20207,100 shares $477.83 -92.6%N/A0 $0.07 7/31/202096,500 shares $6,031.25 +222.7%N/A0.1 $0.06 7/15/202029,900 shares $2,299.31 +121.5%N/A0 $0.08 6/30/202013,500 shares $1,120.50 -59.0%N/A0 $0.08 6/15/202032,900 shares $2,961.00 No ChangeN/A0 $0.09 5/15/202022,200 shares $1,698.30 +27.6%N/A0 $0.08 4/30/202017,400 shares $1,392.00 No ChangeN/A0 $0.08 3/31/20209,600 shares $691.20 +3,100.0%N/A0 $0.07This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 3/13/2020300 shares $18.90 No ChangeN/A0 $0.06 2/28/2020300 shares $24.60 No ChangeN/A0 $0.08 2/14/2020300 shares $27.75 -99.7%N/A0 $0.09 1/31/202085,000 shares $8,670.00 +293.5%N/A0.1 $0.10 1/15/202021,600 shares $2,265.84 +7,100.0%N/A0 $0.10 12/31/2019300 shares $27.45 -98.7%N/A0 $0.09 ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 2,526,500 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 2,526,500 shares, an increase of 52.7% from the previous total of 1,654,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Apogee Therapeutics, Inc. (20.29%), Wave Life Sciences Ltd. (4.54%), Akero Therapeutics, Inc. (4.71%), Mirum Pharmaceuticals, Inc. (14.00%), Tarsus Pharmaceuticals, Inc. (18.78%), CG Oncology, Inc. (12.73%), Disc Medicine, Inc. (10.44%), Amphastar Pharmaceuticals, Inc. (11.51%), Harmony Biosciences Holdings, Inc. (13.46%), Galapagos NV (2.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Apogee Therapeutics Short Interest Wave Life Sciences Short Interest Akero Therapeutics Short Interest Mirum Pharmaceuticals Short Interest Tarsus Pharmaceuticals Short Interest CG Oncology Short Interest Disc Medicine Short Interest Amphastar Pharmaceuticals Short Interest Harmony Biosciences Short Interest Galapagos Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELTP Stock Alerts